BioSyent Inc. (OTCMKTS:BIOYF) Sees Large Drop in Short Interest

BioSyent Inc. (OTCMKTS:BIOYF) saw a significant decline in short interest during the month of February. As of February 28th, there was short interest totalling 1,300 shares, a decline of 23.5% from the February 13th total of 1,700 shares. Based on an average trading volume of 1,200 shares, the short-interest ratio is presently 1.1 days.

BioSyent Stock Performance

Shares of BIOYF opened at $7.84 on Wednesday. The company has a 50-day moving average of $7.70 and a two-hundred day moving average of $7.89. BioSyent has a 12-month low of $5.93 and a 12-month high of $8.90.

BioSyent Increases Dividend

The firm also recently announced a dividend, which was paid on Friday, March 14th. Shareholders of record on Monday, March 3rd were given a dividend of $0.0347 per share. The ex-dividend date was Friday, February 28th. This represents a yield of 1.77%. This is a boost from BioSyent’s previous dividend of $0.03.

About BioSyent

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.